In an advance online article published in Nucleic Acids Research this week, a trio of researchers at Harvard Medical School describes improved and complete enrichment, co-amplification at lower denaturation temperature PCR — or ice-COLD-PCR — which they say "enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations." The team tested the efficacy of ice-COLD-PCR by enriching regions of TP53 in serially diluted mutant and wild-type DNA mixtures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.